China trialling tocilizumab for coronavirus

Patients with severe illness and high levels of interleukin-6 targeted

China is using tocilizumab to treat some people with severe COVID-19 infection, health authorities have said, as the country seeks to build up treatment regimens to help the infected recover.

Patient and chest X-ray signifying coronavirus

Tocilizumab (Actemra) is being prescribed to coronavirus patients who show serious lung damage and have an elevated level of interleukin-6, which could indicate inflammation or immunological diseases, China's National Health Commission says in the latest version of its treatment